Professor Gavin R Screaton

Publications


Journals

  • Scoble JE; Screaton GR; Havard CW. (1990). Renal magnesium wasting in Bartter's syndrome. Nephrol Dial Transplant. 5:388-390.
  • SCREATON GR; CAIRNS HS; COHEN SL. (7 Nov 1991). THE ROLE OF REPERFUSION-INDUCED INJURY IN THE PATHOGENESIS OF THE CRUSH SYNDROME. NEW ENGL J MED. 325:1383-1383.
  • Screaton GR; Singer M; Cairns HS; Thrasher A; Sarner M; Cohen SL. (14 Mar 1992). Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet. 339:677-678.
  • Screaton GR; Bell MV; Jackson DG; Cornelis FB; Gerth U; Bell JI. (15 Dec 1992). Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A. 89:12160-12164.
  • SCREATON GR; BELL MV; JACKSON DG; MCMICHAEL AJ. (9 Jan 1993). PRECISE INTRON-EXON DEFINITION AND SEQUENCE OF ALTERNATIVE SPLICE SITES OF THE ADHESION MOLECULE CD44. J CELL BIOCHEM. 335-335.
  • BELL MV; SCREATON GR; JACKSON DG; BELL JI. (9 Jan 1993). THE GENOMIC ORGANIZATION OF THE HUMAN CD44 GENE. J CELL BIOCHEM. 332-332.
  • JACKSON DG; SCREATON GR; BELL M; BELL JI. (9 Jan 1993). THE STRUCTURE OF THE GENE ENCODING THE ALTERNATIVELY SPLICED CD44 GLYCOPROTEIN. J CELL BIOCHEM. 349-349.
  • JACKSON DG; SCREATON GR; BELL MV; BELL JI. (23 Jan 1993). CD44 AND CANCER. LANCET. 341:252-252.
  • Jackson DG; Screaton GR; Bell MV; Bell JI. (23 Jan 1993). CD44 and cancer. Lancet. 341:252-253.
  • Screaton GR; Bangham CR; Bell JI. (11 May 1993). Direct sequencing of single primer PCR products: a rapid method to achieve short chromosomal walks. Nucleic Acids Res. 21:2263-2264.
  • Screaton GR; Bell MV; Bell JI; Jackson DG. (15 Jun 1993). The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem. 268:12235-12238.
  • Fox SB; Gatter KC; Jackson DG; Screaton GR; Bell MV; Bell JI; Harris AL; Simmons D; et alFawcett J. (28 Aug 1993). CD44 and cancer screening. Lancet. 342:548-549.
  • Hirano H; Screaton GR; Bell MV; Jackson DG; Bell JI; Hodes RJ. (Jan 1994). CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol. 6:49-59.
  • Singer M; McNally T; Screaton G; Mackie I; Machin S; Cohen SL. (1994). Heparin clearance during continuous veno-venous haemofiltration. Intensive Care Med. 20:212-215.
  • Lucassen AM; Screaton GR; Julier C; Elliott TJ; Lathrop M; Bell JI. (Apr 1995). Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype. Hum Mol Genet. 4:501-506.
  • Screaton GR; Cáceres JF; Mayeda A; Bell MV; Plebanski M; Jackson DG; Bell JI; Krainer AR. (1 Sep 1995). Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:4336-4349.
  • Screaton GR; Xu XN; Olsen AL; Cowper AE; Tan R; McMichael AJ; Bell JI. (29 Apr 1997). LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A. 94:4615-4619.
  • Beil B; Screaton G; Stamm S. (Jun 1997). Molecular cloning of htra2-beta-1 and htra2-beta-2, two human homologs of tra-2 generated by alternative splicing. DNA Cell Biol. 16:679-690.
  • Xu XN; Screaton GR; Gotch FM; Dong T; Tan R; Almond N; Walker B; Stebbings R; et alKent K; Nagata S; Stott JE; McMichael AJ. (7 Jul 1997). Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med. 186:7-16. Open Access copy.
  • Cáceres JF; Misteli T; Screaton GR; Spector DL; Krainer AR. (28 Jul 1997). Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol. 138:225-238. Open Access copy.
  • McMichael A; Goulder P; Rowland-Jones S; Phillips R; Xu XN; Screaton G. (31 Jul 1997). Escape from immune control by HIV. FASEB J. 11:A1003-A1003.
  • Screaton GR; Mongkolsapaya J; Xu XN; Cowper AE; McMichael AJ; Bell JI. (1 Sep 1997). TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr Biol. 7:693-696.
  • Cáceres JF; Screaton GR; Krainer AR. (1 Jan 1998). A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12:55-66.
  • Mongkolsapaya J; Cowper AE; Xu XN; Morris G; McMichael AJ; Bell JI; Screaton GR. (1 Jan 1998). Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J Immunol. 160:3-6.
  • Bell MV; Cowper AE; Lefranc MP; Bell JI; Screaton GR. (Oct 1998). Influence of intron length on alternative splicing of CD44. Mol Cell Biol. 18:5930-5941.
  • Tan R; Xu X; Ogg GS; Hansasuta P; Dong T; Rostron T; Luzzi G; Conlon CP; et alScreaton GR; McMichael AJ; Rowland-Jones S. (1 Mar 1999). Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. Blood. 93:1506-1510.
  • Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR. (Mar 1999). Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol Cell Biol. 19:1853-1863.
  • Xu XN; Laffert B; Screaton GR; Kraft M; Wolf D; Kolanus W; Mongkolsapay J; McMichael AJ; et alBaur AS. (3 May 1999). Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med. 189:1489-1496. Open Access copy.
  • Mongkolsapaya J; Grimes JM; Chen N; Xu XN; Stuart DI; Jones EY; Screaton GR. (Nov 1999). Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol. 6:1048-1053. DOI.
  • Gao QS; Memmott J; Lafyatis R; Stamm S; Screaton G; Andreadis A. (Feb 2000). Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J Neurochem. 74:490-500.
  • ten Dam GB; Zilch CF; Wallace D; Wieringa B; Beverley PC; Poels LG; Screaton GR. (15 May 2000). Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J Immunol. 164:5287-5295.
  • Screaton G; Xu XN. (Jun 2000). T cell life and death signalling via TNF-receptor family members. Curr Opin Immunol. 12:316-322.
  • Wei ML; Memmott J; Screaton G; Andreadis A. (15 Sep 2000). The splicing determinants of a regulated exon in the axonal MAP tau reside within the exon and in its upstream intron. Brain Res Mol Brain Res. 80:207-218.
  • Arikan MC; Memmott J; Screaton G; Stamm S; Lafyatis R; Andreadis A. (Dec 2000). Regulation of alternative splicing of the tau projection domain. MOL BIOL CELL. 11:12A-12A.
  • van Der Houven Van Oordt W; Newton K; Screaton GR; Cáceres JF. (15 Dec 2000). Role of SR protein modular domains in alternative splicing specificity in vivo. Nucleic Acids Res. 28:4822-4831.
  • Simon AK; Williams O; Mongkolsapaya J; Jin B; Xu XN; Walczak H; Screaton GR. (24 Apr 2001). Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes. P NATL ACAD SCI USA. 98:5158-5163.
  • Simon AK; Williams O; Mongkolsapaya J; Jin B; Xu XN; Walczak H; Screaton GR. (24 Apr 2001). Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc Natl Acad Sci U S A. 98:5158-5163. DOI.
  • Xu XN; Purbhoo MA; Chen N; Mongkolsapaya J; Cox JH; Meier UC; Tafuro S; Dunbar PR; et alSewell AK; Hourigan CS; Appay V; Cerundolo V; Burrows SR; McMichael AJ; Screaton GR. (May 2001). A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. Immunity. 14:591-602.
  • Xu XN; Screaton G. (May 2001). HIV-1 Nef: negative effector of Fas?. Nat Immunol. 2:384-385. DOI.
  • Xu XN; Screaton GR; McMichael AJ. (Dec 2001). Virus infections: escape, resistance, and counterattack. Immunity. 15:867-870.
  • Cowper AE; Cáceres JF; Mayeda A; Screaton GR. (28 Dec 2001). Serine-arginine (SR) protein-like factors that antagonize authentic SR proteins and regulate alternative splicing. J Biol Chem. 276:48908-48914. DOI.
  • Arikan MC; Memmott J; Broderick JA; Lafyatis R; Screaton G; Stamm S; Andreadis A. (30 May 2002). Modulation of the membrane-binding projection domain of tau protein: splicing regulation of exon 3. Brain Res Mol Brain Res. 101:109-121.
  • Simon AK; Gallimore A; Jones E; Sawitzki B; Cerundolo V; Screaton GR. (Oct 2002). Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. Cancer Cell. 2:315-322.
  • Xu XN; Screaton GR. (1 Oct 2002). MHC/peptide tetramer-based studies of T cell function. J Immunol Methods. 268:21-28.
  • Brackenridge S; Wilkie AO; Screaton GR. (1 Apr 2003). Efficient use of a 'dead-end' GA 5' splice site in the human fibroblast growth factor receptor genes. EMBO J. 22:1620-1631. DOI.
  • Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; et alDong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G. (Jul 2003). Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 9:921-927. DOI.
  • Jones E; Golgher D; Simon AK; Dahm-Vicker M; Screaton G; Elliott T; Gallimore A. (2004). The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice. Novartis Found Symp. 256:149-152.
  • Kimberley FC; Screaton GR. (Oct 2004). Following a TRAIL: update on a ligand and its five receptors. Cell Res. 14:359-372. DOI.
  • Li D; Brackenridge S; Screaton GR. (Dec 2004). A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues. Hum Immunol. 65:1539-1545. DOI.
  • Dong T; Stewart-Jones G; Chen N; Easterbrook P; Xu X; Papagno L; Appay V; Weekes M; et alConlon C; Spina C; Little S; Screaton G; van der Merwe A; Richman DD; McMichael AJ; Jones EY; Rowland-Jones SL. (20 Dec 2004). HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 200:1547-1557. DOI.
  • Drakesmith, H; Chen, N; Ledermann, H; Screaton, G; Townsend, A; Xu, XN. (2005). HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A. 31, 102:11017-11022.
  • Screaton G; Mongkolsapaya J. (2005). T-cell responses and dengue haemorrhagic fever. SYMP SOC GEN MICROBI. 64:15-22.
  • Daniels RA; Turley H; Kimberley FC; Liu XS; Mongkolsapaya J; Ch'En P; Xu XN; Jin BQ; et alPezzella F; Screaton GR. (Jun 2005). Expression of TRAIL and TRAIL receptors in normal and malignant tissues. Cell Res. 15:430-438. DOI.
  • Ch'en PF; Xu XG; Liu XS; Liu Y; Song CJ; Screaton GR; Jin BQ; Xu XN. (Jul 2005). Characterisation of monoclonal antibodies to the TNF and TNF receptor families. Cell Immunol. 236:78-85. DOI.
  • Simon AK; Chen P; Frayne M; Newsom-Davis T; Screaton GR. (Dec 2005). Fas Ligand breaks tolerance to self antigens, induces tumour immunity and helps to generate tumour-rejecting monoclonal antibodies. IMMUNOLOGY. 116:38-38.
  • Richards HE; Simon AK; Jones E; Williams AS; Screaton GR; Gallimore A. (Dec 2005). Inhibition of innate immune responses to tumours by CD4+CD25+ regulatory T cells. IMMUNOLOGY. 116:36-36.
  • Clancy L; Mruk K; Archer K; Woelfel M; Mongkolsapaya J; Screaton G; Lenardo MJ; Chan FKM. (13 Dec 2005). Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. P NATL ACAD SCI USA. 102:18099-18104. DOI.
  • Chan VSF; Chan KYK; Chen YX; Poon LLM; Cheung ANY; Zheng BJ; Chan KH; Mak W; et alNgan HYS; Xu XN; Screaton G; Tam PKH; Austyn JM; Chan LC; Yip SP; Peiris M; Khoo US; Lin CLS. (Jan 2006). Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. NAT GENET. 38:38-46. DOI.
  • Chen N; McCarthy C; Drakesmith H; Li D; Cerundolo V; McMichael AJ; Screaton GR; Xu XN. (Feb 2006). HIV-1 down-regulates the expression of CD1d via Nef. Eur J Immunol. 36:278-286. DOI.
  • Mongkolsapaya J; Duangchinda T; Dejnirattisai W; Vasanawathana S; Avirutnan P; Jairungsri A; Khemnu N; Tangthawornchaikul N; et alChotiyarnwong P; Sae-Jang K; Koch M; Jones Y; McMichael A; Xu X; Malasit P; Screaton G. (15 Mar 2006). T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol. 176:3821-3829.
  • Lobito AA; Kimberley FC; Muppidi JR; Komarow H; Jackson AJ; Hull KM; Kastner DL; Screaton GR; et alSiegel RM. (15 Aug 2006). Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood. 108:1320-1327. DOI.
  • Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Screaton G; Hersey P. (Oct 2006). Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Hum Pathol. 37:1286-1294. DOI.
  • Kimberley FC; Lobito AA; Siegel RM; Screaton GR. (2007). Falling into TRAPS - receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. ARTHRITIS RES THER. 9. DOI.
  • Simon AK; Jones E; Richards H; Wright K; Betts G; Godkin A; Screaton G; Gallimore A. (Mar 2007). Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity. EUR J IMMUNOL. 37:758-767. DOI.
  • Simon AK; Jones E; Richards H; Wright K; Betts G; Godkin A; Screaton G; Gallimore A. (Mar 2007). Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity. Eur J Immunol. 37:758-767. DOI.
  • Chotiyarnwong P; Stewart-Jones GB; Tarry MJ; Dejnirattisai W; Siebold C; Koch M; Stuart DI; Harlos K; et alMalasit P; Screaton G; Mongkolsapaya J; Jones EY. (1 May 2007). Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 63:386-392. DOI.
  • Cox JH; McMichael AJ; Screaton GR; Xu XN. (15 Jul 2007). CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs. J IMMUNOL. 179:830-836.
  • Li D; Chen N; McMichael AJ; Screaton GR; Xu XN. (31 Jan 2008). Generation and characterisation of CD1d tetramer produced by a lentiviral expression system. J Immunol Methods. 330:57-63. DOI.
  • Simon AK; Newsom-Davis T; Frayne ME; Ch'en PF; McMichael AJ; Screaton GR. (Apr 2008). Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand. Int Immunol. 20:525-534. DOI.
  • Patel VK; Pedro VL; Screaton G; Walters JR; Ghosh S. (Apr 2008). Peripheral blood from Crohn's disease patients demonstrate both IL-17 expressing CD4+ lymphocytes and IL-17 and interferon-gamma double expressing CD4+ lymphocytes. GASTROENTEROLOGY. 134:A508-A508.
  • Cooper WA; Kohonen-Corish MR; Zhuang L; McCaughan B; Kennedy C; Screaton G; Sutherland RL; Lee CS. (1 Jul 2008). Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions. Cancer. 113:135-142. DOI.
  • Li CK; Wu H; Yan H; Ma S; Wang L; Zhang M; Tang X; Temperton NJ; et alWeiss RA; Brenchley JM; Douek DC; Mongkolsapaya J; Tran BH; Lin CL; Screaton GR; Hou JL; McMichael AJ; Xu XN. (15 Oct 2008). T cell responses to whole SARS coronavirus in humans. J Immunol. 181:5490-5500.
  • Dejnirattisai W; Duangchinda T; Lin CL; Vasanawathana S; Jones M; Jacobs M; Malasit P; Xu XN; et alScreaton G; Mongkolsapaya J. (1 Nov 2008). A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J Immunol. 181:5865-5874.
  • Dharmapatni AA; Smith MD; Findlay DM; Holding CA; Evdokiou A; Ahern MJ; Weedon H; Chen P; et alScreaton G; Xu XN; Haynes DR. (2009). Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther. 11:R13. DOI.
  • Li D; Wang L; Yu L; Freundt EC; Jin B; Screaton GR; Xu XN. (15 Jan 2009). Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction. J Immunol. 182:1033-1040.
  • Newsom-Davis TE; Wang D; Steinman L; Chen PFT; Wang LX; Simon AK; Screaton GR. (1 Mar 2009). Enhanced Immune Recognition of Cryptic Glycan Markers in Human Tumors. CANCER RES. 69:2018-2025. DOI.
  • Freundt EC; Yu L; Goldsmith CS; Welsh S; Cheng A; Yount B; Liu W; Frieman MB; et alBuchholz UJ; Screaton GR; Lippincott-Schwartz J; Zaki SR; Xu XN; Baric RS; Subbarao K; Lenardo MJ. (15 Jan 2010). The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death. J VIROL. 84:1097-1109. DOI.
  • Dejnirattisai W; Jumnainsong A; Onsirisakul N; Fitton P; Vasanawathana S; Limpitikul W; Puttikhunt C; Edwards C; et alDuangchinda T; Supasa S; Chawansuntati K; Malasit P; Mongkolsapaya J; Screaton G. (7 May 2010). Cross-reacting antibodies enhance dengue virus infection in humans. Science. 328:745-748. DOI.
  • Weng L; Williams RO; Vieira PL; Screaton G; Feldmann M; Dazzi F. (Aug 2010). The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activity. Ann Rheum Dis. 69:1519-1526. DOI.
  • Duangchinda T; Dejnirattisai W; Vasanawathana S; Limpitikul W; Tangthawornchaikul N; Malasit P; Mongkolsapaya J; Screaton G. (28 Sep 2010). Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A. 107:16922-16927. DOI.
  • Midgley CM; Bajwa-Joseph M; Vasanawathana S; Limpitikul W; Wills B; Flanagan A; Waiyaiya E; Tran HB; et alCowper AE; Chotiyarnwong P; Grimes JM; Yoksan S; Malasit P; Simmons CP; Mongkolsapaya J; Screaton GR. (Jan 2011). An in-depth analysis of original antigenic sin in dengue virus infection. J Virol. 85:410-421. DOI.
  • Watson AA; Lebedev AA; Hall BA; Fenton-May AE; Vagin AA; Dejnirattisai W; Felce J; Mongkolsapaya J; et alPalma AS; Liu Y; Feizi T; Screaton GR; Murshudov GN; O'Callaghan CA. (8 Jul 2011). Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling. J Biol Chem. 286:24208-24218. DOI.
  • Dejnirattisai W; Webb AI; Chan V; Jumnainsong A; Davidson A; Mongkolsapaya J; Screaton G. (15 Jun 2011). Lectin switching during dengue virus infection. J Infect Dis. 203:1775-1783. DOI.
  • Midgley CM; Bajwa-Joseph M; Vasanawathana S; Limpitikul W; Wills B; Flanagan A; Waiyaiya E; Tran HB; et alCowper AE; Chotiyarnwong P; Grimes JM; Yoksan S; Malasit P; Simmons CP; Mongkolsapaya J; Screaton GR. (Nov 2011). An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection (vol 85, pg 410, 2011). J VIROL. 85:12100-12100. DOI.

Conferences

  • Rihoskova V; Daniels R; Seemayer CA; Screaton GR; Gay RE; Gay S. Expression of trail and its receptors in rheumatoid arthritis (RA). Annual European Congress of Rheumatology. 62:106-107. (Jul 2003).
  • Rihoskova V; Seemayer CA; Hirth A; Daniels R; Screaton GR; Simmen BR; Michel BA; Gay RE; et alGay S. Expression and biological function of Trail and its receptors in rheumatoid arthritis (ra). 48:S340-S340. (Sep 2003).
  • Dharmapatni AASSK; Findlay DM; Smith MD; Evdokiou A; Chen P; Screaton GR; Xu XN; Holding C; et alHaynes DR. Regulating the sensitivity of synovial fibroblasts to trail-induced apoptosis. 64:154-154. (Jul 2005).
  • Vieira PL; Lebre MC; Aarrass S; Newsom-Davis T; Tak PP; Screaton GR. EXPANSIONS OF INTERLEUKIN 21-SECRETING CD4 T HELPER CELLS IN INFLAMMATORY ARTHRITIDES. 69:A68-A68. (Feb 2010). DOI.
  • Screaton G. Immunopathology in dengue virus infection. 131:9-10. (Dec 2010).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook